ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
Michele Ghielmini(Institute of Oncology Research), Markus Raderer(Medical University of Vienna), Robert Marcus(Cancer Clinic), Silvia Montoto(Queen Mary University of London), Francesco d’Amore(Aarhus University), Armando López‐Guillermo(Barcelona Supercomputing Center), Carlos Montalbán, Philippe Gaulard(Inserm), Michael Pfreundschuh(Saarland University), Emilio Iannitto, Andrea Gallamini(Centre Antoine Lacassagne), Steven Le Gouill(Inserm), Luca Arcaini(University of Pavia), Stephan Stilgenbauer(Universität Ulm), Peter Hoskin(University of Manchester), María Gomes da Silva(Instituto Português de Oncologia Francisco Gentil), Elı́as Campo(Hospital Clínic de Barcelona), Massimo Federico(University of Modena and Reggio Emilia), Hanneke C. Kluin‐Nelemans(University Medical Center Groningen), P. Koch(Pius Hospital Oldenburg), Martin Dreyling(LMU Klinikum), Christopher McNamara(The Royal Free Hospital), Paolo Corradini(Gruppo di Ricerca Geriatrica), Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology), Olivier Hermine(Centre National de la Recherche Scientifique), Eva Kimby(Karolinska University Hospital), John G. Gribben(Queen Mary University of London), Emili Montserrat(Universitat de Barcelona), R. Marcus(Cancer Clinic), Won Seog Kim(Samsung Medical Center), Marco Ladetto(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Peter Dreger(Heidelberg University), Christian Gisselbrecht(Institut Universitaire de France), Marek Trněný(Charles University), Federico Caligaris‐Cappio(Vita-Salute San Raffaele University), Peter Dreger(Heidelberg University), Claudio Agostinelli, Christian H. Geisler(Copenhagen University Hospital), Umberto Vitolo(Candiolo Cancer Institute), M. Dreyling(Ludwig-Maximilians-Universität München), Bertrand Coiffier(Unknown)
Cited by 218
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k